Efficacy and safety of semaglutide in non-alcoholic fatty liver disease

doi:10.3748/wjg.v29.i37.5327

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9582)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

125

WORD

HTML

7098

Figures (1-6)

380

Tables (1-2)

242

Sum=7885

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

266

Download

441

Sum=707

Publishing Process of This Article

Item

Count

Browse

171

Download

426

Sum=597

Oct 7, 2023 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Gastroenterol. Oct 7, 2023; 29(37): 5327-5338
Published online Oct 7, 2023. doi: 10.3748/wjg.v29.i37.5327

Full Size Figure Download Figure

Figure 1 PRISMA flow diagram of study selection. WHO: World health organization.

Citation: Zhu K, Kakkar R, Chahal D, Yoshida EM, Hussaini T. Efficacy and safety of semaglutide in non-alcoholic fatty liver disease. World J Gastroenterol 2023; 29(37): 5327-5338
URL: https://www.wjgnet.com/1007-9327/full/v29/i37/5327.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i37.5327